Fentanyl: Clinical Trials

5 trials for Fentanyl, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 2 unknown, 1 completed. 5 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Terminated 2, Unknown 2, Completed 1
Phase 22Completed 1, Unknown 1

Follow Fentanyl: new trials by email Literature Review of Fentanyl trials Research Report on Fentanyl

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fentanyl OR Esketamine for Traumatic PAIN (FORE-PAIN) Trial
Fentanyl Citrate, Esketamine - Acute Pain Due to Trauma, Analgesia
Phase 3TerminatedAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2352024-01-112026-09-15
Fentanyl Versus Dexmedetomidine as an Adjuvant to Bupivacaine in Spinal Anesthesia ; Peritoneal Symptomatic Effects
Dexmedetomidine Injection [Precedex], Fentanyl HCl - Dexmedetomidine, Fentanyl
Phase 3UnknownAswan University1482023-07-012025-02-21
Effect of Topically Administered Levobupivacaine- Fentanyl Versus Levobupivacaine- Dexamethasone Combination in the Control of Pain After Endoscopic Sinus Surgery
Saline 0.9%, Levobupivacaine Hydrochloride, Fentanyl - Endoscopic Sinus Surgery, Fentanyl
Phase 2 / Phase 3UnknownAssiut University802021-12-012021-12-06
Slow-Release Oral Morphine for the Treatment of Opioid Use Disorder
Slow release oral morphine (SROM), Methadone - Opioid-Related Disorders, Opiate Substitution Treatment
Phase 3TerminatedM. Eugenia Socias272019-12-062022-02-10
Dexmedetomidine to Levobupivacaine for Transversus Abdominis Plane Block in Elderly Patients Undergoing Inguinal Hernia Repair Surgery
Levobupivacaine, Dexmedetomidine Hydrochloride, Fentanyl - Dexmedetomidine, Fentanyl
Phase 2 / Phase 3CompletedAssiut University902019-12-012021-07-21

Narrower conditions

Agnosia (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Opioid-Related Disorders (1)

Broader conditions

Chemically-Induced Disorders (2)  ·  Mental Disorders (1)  ·  Narcotic-Related Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Perceptual Disorders (1)  ·  Signs and Symptoms (1)  ·  Substance-Related Disorders (1)

Interventions

Fentanyl (3)  ·  Dexmedetomidine (2)  ·  Levobupivacaine (2)  ·  Dexamethasone (1)  ·  Esketamine (1)  ·  Methadone (1)  ·  Morphine (1)  ·  Sodium Chloride (1)

Sponsors

Assiut University (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Aswan University (1)  ·  M. Eugenia Socias (1)

Countries

Egypt (3)  ·  Canada (1)  ·  Netherlands (1)

Top investigators

Ahmed A Mahmoud, MD (1)  ·  Ayman M Eldemrdash, MD (1)  ·  M. Eugenia Socias, MD, MSc (1)  ·  Markus W Hollmann, Prof. dr. dr. (1)

Results publications

PMID 23160979, PMID 23355160, PMID 23389068, PMID 37811840, PMID 40420189